197 related articles for article (PubMed ID: 18685809)
1. Molecular dynamics simulation study of PTP1B with allosteric inhibitor and its application in receptor based pharmacophore modeling.
Bharatham K; Bharatham N; Kwon YJ; Lee KW
J Comput Aided Mol Des; 2008 Dec; 22(12):925-33. PubMed ID: 18685809
[TBL] [Abstract][Full Text] [Related]
2. Binding and discerning interactions of PTP1B allosteric inhibitors: novel insights from molecular dynamics simulations.
Shinde RN; Sobhia ME
J Mol Graph Model; 2013 Sep; 45():98-110. PubMed ID: 24012873
[TBL] [Abstract][Full Text] [Related]
3. Screening and identification of potential PTP1B allosteric inhibitors using in silico and in vitro approaches.
Shinde RN; Kumar GS; Eqbal S; Sobhia ME
PLoS One; 2018; 13(6):e0199020. PubMed ID: 29912965
[TBL] [Abstract][Full Text] [Related]
4. In silico investigations on the binding efficacy and allosteric mechanism of six different natural product compounds towards PTP1B inhibition through docking and molecular dynamics simulations.
SarathKumar B; Lakshmi BS
J Mol Model; 2019 Aug; 25(9):272. PubMed ID: 31451955
[TBL] [Abstract][Full Text] [Related]
5. Unraveling the allosteric inhibition mechanism of PTP1B by free energy calculation based on umbrella sampling.
Cui W; Cheng YH; Geng LL; Liang DS; Hou TJ; Ji MJ
J Chem Inf Model; 2013 May; 53(5):1157-67. PubMed ID: 23621621
[TBL] [Abstract][Full Text] [Related]
6. The mechanism of allosteric inhibition of protein tyrosine phosphatase 1B.
Li S; Zhang J; Lu S; Huang W; Geng L; Shen Q; Zhang J
PLoS One; 2014; 9(5):e97668. PubMed ID: 24831294
[TBL] [Abstract][Full Text] [Related]
7. Molecular dynamics approach to probe the allosteric inhibition of PTP1B by chlorogenic and cichoric acid.
Baskaran SK; Goswami N; Selvaraj S; Muthusamy VS; Lakshmi BS
J Chem Inf Model; 2012 Aug; 52(8):2004-12. PubMed ID: 22747429
[TBL] [Abstract][Full Text] [Related]
8. Alpha7 helix plays an important role in the conformational stability of PTP1B.
Olmez EO; Alakent B
J Biomol Struct Dyn; 2011 Apr; 28(5):675-93. PubMed ID: 21294582
[TBL] [Abstract][Full Text] [Related]
9. Identification of flavonolignans from Silybum marianum seeds as allosteric protein tyrosine phosphatase 1B inhibitors.
Qin N; Sasaki T; Li W; Wang J; Zhang X; Li D; Li Z; Cheng M; Hua H; Koike K
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1283-1291. PubMed ID: 30160205
[TBL] [Abstract][Full Text] [Related]
10. Prediction of enzyme inhibition and mode of inhibitory action based on calculation of distances between hydrogen bond donor/acceptor groups of the molecule and docking analysis: An application on the discovery of novel effective PTP1B inhibitors.
Eleftheriou P; Petrou A; Geronikaki A; Liaras K; Dirnali S; Anna M
SAR QSAR Environ Res; 2015; 26(7-9):557-76. PubMed ID: 26294069
[TBL] [Abstract][Full Text] [Related]
11. Selective binding modes and allosteric inhibitory effects of lupane triterpenes on protein tyrosine phosphatase 1B.
Jin T; Yu H; Huang XF
Sci Rep; 2016 Feb; 6():20766. PubMed ID: 26865097
[TBL] [Abstract][Full Text] [Related]
12. Flavonoids as potent allosteric inhibitors of protein tyrosine phosphatase 1B: molecular dynamics simulation and free energy calculation.
Zargari F; Lotfi M; Shahraki O; Nikfarjam Z; Shahraki J
J Biomol Struct Dyn; 2018 Nov; 36(15):4126-4142. PubMed ID: 29216799
[TBL] [Abstract][Full Text] [Related]
13. The discovery of a novel and selective inhibitor of PTP1B over TCPTP: 3D QSAR pharmacophore modeling, virtual screening, synthesis, and biological evaluation.
Ma Y; Jin YY; Wang YL; Wang RL; Lu XH; Kong DX; Xu WR
Chem Biol Drug Des; 2014 Jun; 83(6):697-709. PubMed ID: 24418013
[TBL] [Abstract][Full Text] [Related]
14. Integrated use of ligand and structure-based virtual screening, molecular dynamics, free energy calculation and ADME prediction for the identification of potential PTP1B inhibitors.
Devi B; Vasishta SS; Das B; Baidya ATK; Rampa RS; Mahapatra MK; Kumar R
Mol Divers; 2024 Apr; 28(2):649-669. PubMed ID: 36745307
[TBL] [Abstract][Full Text] [Related]
15. Native dynamics and allosteric responses in PTP1B probed by high-resolution HDX-MS.
Woods VA; Abzalimov RR; Keedy DA
Protein Sci; 2024 Jun; 33(6):e5024. PubMed ID: 38801229
[TBL] [Abstract][Full Text] [Related]
16. PTP1b Inhibition, A Promising Approach for the Treatment of Diabetes Type II.
Eleftheriou P; Geronikaki A; Petrou A
Curr Top Med Chem; 2019; 19(4):246-263. PubMed ID: 30714526
[TBL] [Abstract][Full Text] [Related]
17. Pyrrolo[1,2-a]quinoxal-5-inium salts and 4,5-dihydropyrrolo[1,2-a]quinoxalines: Synthesis, activity and computational docking for protein tyrosine phosphatase 1B.
Sánchez-Alonso P; Griera M; García-Marín J; Rodríguez-Puyol M; Alajarín R; Vaquero JJ; Rodríguez-Puyol D
Bioorg Med Chem; 2021 Aug; 44():116295. PubMed ID: 34246920
[TBL] [Abstract][Full Text] [Related]
18. Discovery of novel PTP1B inhibitors via pharmacophore-oriented scaffold hopping from Ertiprotafib.
Liu JZ; Zhang SE; Nie F; Yang Y; Tang YB; Yin W; Tian JY; Ye F; Xiao Z
Bioorg Med Chem Lett; 2013 Dec; 23(23):6217-22. PubMed ID: 24148325
[TBL] [Abstract][Full Text] [Related]
19. Pharmacophore modeling for protein tyrosine phosphatase 1B inhibitors.
Bharatham K; Bharatham N; Lee KW
Arch Pharm Res; 2007 May; 30(5):533-42. PubMed ID: 17615669
[TBL] [Abstract][Full Text] [Related]
20. Identification of protein tyrosine phosphatase 1B (PTP1B) inhibitors through De Novo Evoluton, synthesis, biological evaluation and molecular dynamics simulation.
Wu J; Ma Y; Zhou H; Zhou L; Du S; Sun Y; Li W; Dong W; Wang R
Biochem Biophys Res Commun; 2020 May; 526(1):273-280. PubMed ID: 32209254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
